136 related articles for article (PubMed ID: 32157737)
1. Endothelin receptor B controls the production of fibroblast growth factor 23.
Feger M; Ewendt F; Menzel M; Hocher B; Föller M
FASEB J; 2020 May; 34(5):6262-6270. PubMed ID: 32157737
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoids dexamethasone and prednisolone suppress fibroblast growth factor 23 (FGF23).
Feger M; Ewendt F; Strotmann J; Schäffler H; Kempe-Teufel D; Glosse P; Stangl GI; Föller M
J Mol Med (Berl); 2021 May; 99(5):699-711. PubMed ID: 33517471
[TBL] [Abstract][Full Text] [Related]
3. Klotho Lacks an FGF23-Independent Role in Mineral Homeostasis.
Andrukhova O; Bayer J; Schüler C; Zeitz U; Murali SK; Ada S; Alvarez-Pez JM; Smorodchenko A; Erben RG
J Bone Miner Res; 2017 Oct; 32(10):2049-2061. PubMed ID: 28600880
[TBL] [Abstract][Full Text] [Related]
4. Parathyroid hormone 1 receptor is essential to induce FGF23 production and maintain systemic mineral ion homeostasis.
Fan Y; Bi R; Densmore MJ; Sato T; Kobayashi T; Yuan Q; Zhou X; Erben RG; Lanske B
FASEB J; 2016 Jan; 30(1):428-40. PubMed ID: 26428657
[TBL] [Abstract][Full Text] [Related]
5. 1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport.
Kolek OI; Hines ER; Jones MD; LeSueur LK; Lipko MA; Kiela PR; Collins JF; Haussler MR; Ghishan FK
Am J Physiol Gastrointest Liver Physiol; 2005 Dec; 289(6):G1036-42. PubMed ID: 16020653
[TBL] [Abstract][Full Text] [Related]
6. Regulation of serum 1,25(OH)2 vitamin D3 levels by fibroblast growth factor 23 is mediated by FGF receptors 3 and 4.
Gattineni J; Twombley K; Goetz R; Mohammadi M; Baum M
Am J Physiol Renal Physiol; 2011 Aug; 301(2):F371-7. PubMed ID: 21561999
[TBL] [Abstract][Full Text] [Related]
7. Klotho expression in long bones regulates FGF23 production during renal failure.
Kaludjerovic J; Komaba H; Sato T; Erben RG; Baron R; Olauson H; Larsson TE; Lanske B
FASEB J; 2017 May; 31(5):2050-2064. PubMed ID: 28183805
[TBL] [Abstract][Full Text] [Related]
8. p38MAPK controls fibroblast growth factor 23 (FGF23) synthesis in UMR106-osteoblast-like cells and in IDG-SW3 osteocytes.
Ewendt F; Föller M
J Endocrinol Invest; 2019 Dec; 42(12):1477-1483. PubMed ID: 31201665
[TBL] [Abstract][Full Text] [Related]
9. Enhanced FGF23 production in mice expressing PI3K-insensitive GSK3 is normalized by β-blocker treatment.
Fajol A; Chen H; Umbach AT; Quarles LD; Lang F; Föller M
FASEB J; 2016 Feb; 30(2):994-1001. PubMed ID: 26527066
[TBL] [Abstract][Full Text] [Related]
10. Bone formation regulates circulating concentrations of fibroblast growth factor 23.
Samadfam R; Richard C; Nguyen-Yamamoto L; Bolivar I; Goltzman D
Endocrinology; 2009 Nov; 150(11):4835-45. PubMed ID: 19819968
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
Koizumi M; Komaba H; Fukagawa M
Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D.
Liu S; Tang W; Zhou J; Stubbs JR; Luo Q; Pi M; Quarles LD
J Am Soc Nephrol; 2006 May; 17(5):1305-15. PubMed ID: 16597685
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin stimulates fibroblast growth factor 23 (FGF23) in mice and men.
Daryadel A; Bettoni C; Haider T; Imenez Silva PH; Schnitzbauer U; Pastor-Arroyo EM; Wenger RH; Gassmann M; Wagner CA
Pflugers Arch; 2018 Oct; 470(10):1569-1582. PubMed ID: 29961920
[TBL] [Abstract][Full Text] [Related]
14. Regulation of fibroblast growth factor 23 (FGF23) in health and disease.
Bär L; Stournaras C; Lang F; Föller M
FEBS Lett; 2019 Aug; 593(15):1879-1900. PubMed ID: 31199502
[TBL] [Abstract][Full Text] [Related]
15. 1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism.
Barthel TK; Mathern DR; Whitfield GK; Haussler CA; Hopper HA; Hsieh JC; Slater SA; Hsieh G; Kaczmarska M; Jurutka PW; Kolek OI; Ghishan FK; Haussler MR
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):381-8. PubMed ID: 17293108
[TBL] [Abstract][Full Text] [Related]
16. Dietary phosphate supplement does not rescue skeletal phenotype in a mouse model for craniometaphyseal dysplasia.
Liu Y; Dutra EH; Reichenberger EJ; Chen IP
J Negat Results Biomed; 2016 Oct; 15(1):18. PubMed ID: 27784318
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D and type II sodium-dependent phosphate cotransporters.
Kido S; Kaneko I; Tatsumi S; Segawa H; Miyamoto K
Contrib Nephrol; 2013; 180():86-97. PubMed ID: 23652552
[TBL] [Abstract][Full Text] [Related]
18. Bone mineralization is regulated by signaling cross talk between molecular factors of local and systemic origin: the role of fibroblast growth factor 23.
Sapir-Koren R; Livshits G
Biofactors; 2014; 40(6):555-68. PubMed ID: 25352227
[TBL] [Abstract][Full Text] [Related]
19. In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis.
Nakatani T; Sarraj B; Ohnishi M; Densmore MJ; Taguchi T; Goetz R; Mohammadi M; Lanske B; Razzaque MS
FASEB J; 2009 Feb; 23(2):433-41. PubMed ID: 18835926
[TBL] [Abstract][Full Text] [Related]
20. A Control Region Near the Fibroblast Growth Factor 23 Gene Mediates Response to Phosphate, 1,25(OH)2D3, and LPS In Vivo.
Lee SM; Carlson AH; Onal M; Benkusky NA; Meyer MB; Pike JW
Endocrinology; 2019 Dec; 160(12):2877-2891. PubMed ID: 31599948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
